CLOVER HEALTH INVESTMENTS, CORP. /DE

CLOV Nasdaq CIK: 0001801170

Company Information

Industry Hospital & Medical Service Plans
SIC Code 6324
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
Mailing Address C/O THE CORPORATION TRUST COMPANY, WILMINGTON, DE, 19801
Phone (201) 432-2133
Fiscal Year End 1231
EIN 981515192

Financial Overview

FY2025

$541.01M
Total Assets

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 26, 2026 View on SEC
4 Insider stock transaction report March 18, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
4 Insider stock transaction report March 17, 2026 View on SEC
8-K Current report of material events March 6, 2026 View on SEC
8-K/A Current report amendment March 6, 2026 View on SEC
4 Insider stock transaction report March 5, 2026 View on SEC
10-K Annual financial report February 27, 2026 View on SEC
8-K Current report of material events February 26, 2026 View on SEC

Annual Reports

10-K February 27, 2026
  • Achieved 12% revenue growth to $1.8 billion in 2025, driven by expanded Medicare Advantage membership.
  • Reduced net loss by a significant 30% to $120 million, reflecting an improved Medical Loss Ratio of 88%.
View Analysis

Insider Trading

SELL 2 insiders 5 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 6324)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.